Cargando…
Role of CD47-SIRPα Checkpoint in Nanomedicine-Based Anti-Cancer Treatment
Many cancers have evolved various mechanisms to evade immunological surveillance, such as the inhibitory immune checkpoint of the CD47-SIRPα signaling pathway. By targeting this signaling pathway, researchers have developed diverse nanovehicles with different loaded drugs and modifications in antica...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087583/ https://www.ncbi.nlm.nih.gov/pubmed/35557862 http://dx.doi.org/10.3389/fbioe.2022.887463 |